BlackRock’s Climb Bio, Inc. Common Stock CLYM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.09M | Sell |
877,969
-1,418,455
| -62% | -$1.76M | ﹤0.01% | 4155 |
|
|
2025
Q1 | $2.8M | Sell |
2,296,424
-9,831
| -0.4% | -$12K | ﹤0.01% | 3840 |
|
|
2024
Q4 | $4.15M | Buy |
2,306,255
+439,158
| +24% | +$790K | ﹤0.01% | 3753 |
|
|
2024
Q3 | $9.5M | Buy |
1,867,097
+1,485,374
| +389% | +$7.56M | ﹤0.01% | 3392 |
|
|
2024
Q2 | $2.71M | Buy |
381,723
+351,283
| +1,154% | +$2.5M | ﹤0.01% | 3831 |
|
|
2024
Q1 | $83.4K | Sell |
30,440
-705
| -2% | -$1.93K | ﹤0.01% | 4713 |
|
|
2023
Q4 | $84.1K | Sell |
31,145
-166
| -0.5% | -$448 | ﹤0.01% | 4779 |
|
|
2023
Q3 | $82.3K | Sell |
31,311
-581
| -2% | -$1.53K | ﹤0.01% | 4838 |
|
|
2023
Q2 | $89.3K | Sell |
31,892
-809
| -2% | -$2.27K | ﹤0.01% | 4862 |
|
|
2023
Q1 | $94.8K | Buy |
32,701
+498
| +2% | +$1.44K | ﹤0.01% | 4885 |
|
|
2022
Q4 | $118K | Buy |
32,203
+332
| +1% | +$1.22K | ﹤0.01% | 4904 |
|
|
2022
Q3 | $102K | Sell |
31,871
-415
| -1% | -$1.33K | ﹤0.01% | 5080 |
|
|
2022
Q2 | $97K | Sell |
32,286
-307,059
| -90% | -$923K | ﹤0.01% | 5159 |
|
|
2022
Q1 | $2.85M | Sell |
339,345
-17,099
| -5% | -$143K | ﹤0.01% | 4154 |
|
|
2021
Q4 | $3.73M | Buy |
356,444
+24,318
| +7% | +$254K | ﹤0.01% | 4062 |
|
|
2021
Q3 | $5.97M | Buy |
+332,126
| New | +$5.97M | ﹤0.01% | 3831 |
|